https://www.selleckchem.com/products/Cyt387.html
ology of immune-related pneumonitis will be crucial to guide more precise and effective treatment strategies in the future. Steroid-refractory or -resistant immune checkpoint pneumonitis is uncommon but associated with significant morbidity and mortality. Additional immunomodulators can yield durable improvement, attained in over one third of patients. An improved understanding of the underlying biology of immune-related pneumonitis will be crucial to guide more precise and effective treatment strategies in the future. To examine the ass